MYST2 histone acetyltransferase promotes lung adenocarcinoma progression by regulating the p38 MAPK signaling pathway
These findings suggest that MYST2 acts as an oncogene in lung cancer by modulating p38 phosphorylation through the MYST domain, underscoring its potential as a prognostic marker and therapeutic target.
Authors
- Zhiang Huang
- Mengyao Wu (ORCID: https://orcid.org/0000-0003-2082-0885)
- Yongsheng Guo (ORCID: https://orcid.org/0000-0001-7609-1891)
- Jingying Chen (ORCID: https://orcid.org/0000-0002-3159-1101)
- Wanru Zhang
- Ping Wang (ORCID: https://orcid.org/0000-0001-6712-8939)
Institutions
- Henan University (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1016/j.tranon.2024.102218
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00